GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
7SOB | P0DTC2 | SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement | |
7SOB | 7SOB | SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement | |
7SOE | P0DTC2 | SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement | |
7SOE | 7SOE | SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement | |
7TM0 | P0DTC2 | SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement | |
7TM0 | 7TM0 | SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement | |
7TLY | 7TLY | SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) | |
7TLY | P0DTC2 | SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) | |
7T3M | P0DTC2 | SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map | |
7T3M | 7T3M | SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map | |
7T67 | P0DTC2 | SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up | |
8VYE | 8VYE | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | |
8VYE | P0DTC2 | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | |
7N8H | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
7N8H | 7N8H | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
7N8I | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
7N8I | 7N8I | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
8DCC | P0DTC2 | SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab | |
8DCC | 8DCC | SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab | |
7BH9 | Q9BYF1 | SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain | |
7BH9 | P0DTC2 | SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain | |
7KDH | P0DTC2 | SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | Spike glycoprotein |
8E1G | P0DTC2 | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
8E1G | 8E1G | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
7KLH | P0DTC2 | SARS-CoV-2 RBD in complex with Fab 15033-7 | |
7KLH | 7KLH | SARS-CoV-2 RBD in complex with Fab 15033-7 | |
7KLG | P0DTC2 | SARS-CoV-2 RBD in complex with Fab 15033 | |
7KLG | 7KLG | SARS-CoV-2 RBD in complex with Fab 15033 | |
7F3Q | P0DTC2 | SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab | |
7F3Q | 7F3Q | SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab | |
7KDG | P0DTC2 | SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | Spike glycoprotein |
8EL2 | P0DTC2 | SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23 | |
8EL2 | 8EL2 | SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23 | |
8XSF | Q9BYF1 | SARS-CoV-2 RBD + IMCAS-364 + hACE2 | |
8XSF | P0DTC2 | SARS-CoV-2 RBD + IMCAS-364 + hACE2 | |
8XSF | 8XSF | SARS-CoV-2 RBD + IMCAS-364 + hACE2 | |
8XSI | P0DTC2 | SARS-CoV-2 RBD + IMCAS-364 (Local Refinement) | |
8XSI | 8XSI | SARS-CoV-2 RBD + IMCAS-364 (Local Refinement) | |
8XSE | P0DTC2 | SARS-CoV-2 RBD + IMCAS-123 + IMCAS-72 Fab | |
8XSE | 8XSE | SARS-CoV-2 RBD + IMCAS-123 + IMCAS-72 Fab | |
8UKD | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.5) | |
8V0U | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 4 (S-GSAS-Omicron-XBB.1.5) | |
8V0T | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-XBB.1.5) | |
8V0S | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.5) | |
8V0R | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-XBB.1.5) | |
8UK1 | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer consensus (S-RRAR-Omicron-XBB.1.16) | |
8V0N | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 3 (S-RRAR-Omicron-XBB.1.16) | |
8V0M | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 2 (S-RRAR-Omicron-XBB.1.16) | |
8V0L | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 1 (S-RRAR-Omicron-XBB.1.16) | |
8UIR | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.16) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024